Highlights Prevalence of pulmonary thromboembolic disease (PTE) is 38% in COVID-19 patients who underwent CTPA. Patients with more severe COVID-19 changes are more likely to have PTE. Majority of PTE is observed within smaller pulmonary vessels (75%) and lungs demonstrating COVID-19 changes (72%). Subsegmental vessels should be scrutinized for presence of PTE. D-dimer values may have potential in guiding anticoagulation therapy and evaluating prognosis in these patients.

The study highlighted the need to include a whole-level approach in organisation to improve research culture and to include communication within the Cooke's framework if evidence-based practice is to influence the quality of patient care.